Alan B. Glassberg
Corporate Officer/Principal chez The University of California, San Francisco
Postes actifs de Alan B. Glassberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | 01/01/1970 | - |
Historique de carrière de Alan B. Glassberg
Anciens postes connus de Alan B. Glassberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOGEN INC. | Directeur/Membre du Conseil | 01/01/1997 | 01/06/2009 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Directeur/Membre du Conseil | 01/01/1997 | 31/12/2008 |
| PONIARD PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 24/08/2006 | 15/03/2007 |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - | - |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Corporate Officer/Principal | 16/12/2010 | - |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Directeur/Membre du Conseil | 01/01/1997 | - |
Formation de Alan B. Glassberg
| College of Charleston | Undergraduate Degree |
| Medical University of South Carolina | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 10 |
Opérationnelle
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
- Bourse
- Insiders
- Alan B. Glassberg
- Expérience
